A Practical Approach to Early-Phase CMC
February 20, 2026
Integrated, risk-based chemistry, manufacturing and controls strategies support early-phase development, writes Richard Chubb
6 min read
False
Advertisement
Development & Clinical
Building Better Oral Suspensions for Pediatric & Real-World Use
February 18, 2026
Greg Thomas, Kiel Laboratories’ Vice President of R&D, discusses oral suspensions, excipients, and patient-centered formulation
4 min read
Training the Medicine Makers the UK Can’t Afford to Lose
February 12, 2026
Why immersive training could be critical to closing the UK’s medicines manufacturing skills gap
4 min read
Enhancing Sterile Drug Quality with AI-Driven Inspection
By Christy Eatmon
February 9, 2026
Bringing speed, consistency, and insight to sterile drug inspection
3 min read
The Role of AI in Rare Disease Drug Discovery
By Dan Williams
February 6, 2026
AI, data-sharing, and gene technologies are peering into the future of rare disease drug development, and overcoming economic, regulatory, and diagnostic challenges for transformative therapies.
9 min read
Five Ways AI Will Reshape Life Sciences in 2026
By Chris Moore
February 5, 2026
Why people, process, and purpose matter most
5 min read
Beckman Coulter and Automata in Agentic AI Partnership
February 5, 2026
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
1 min read
How Speed, Scale, and Science Can Personalize the Pandemic Response
By Andrew Lewis
January 20, 2026
Decades of research have made mRNA a platform for fast, flexible therapeutic innovation, but its promise depends on partnerships.
4 min read
New START for Kumar Muthalagappan
January 20, 2026
Entrepreneur and philanthropist will assist South Texas Accelerated Research Therapeutics (START) in its quest to expand globally
2 min read
First Preclinical Development Candidate for Nucleome Therapeutics
January 19, 2026
First-in-class monoclonal antibody agonist program for inflammation
2 min read
